Respi Peds Dx™
Acute respiratory infection is a significant cause of illness in children. VolenteDx is proud to offer our best-in-industry Respi Peds Dx™ diagnostic panel. Many respiratory symptoms overlap, making it difficult for parents, teachers and physicians to distinguish between infections. Co-infection with multiple organisms is also common within this patient population and it is not uncommon for children to have six or more respiratory infections per year. It is therefore very important to have access to advanced technology to detect and distinguish between multiple pathogens that may be present in a child at once. Early diagnosis is important for the avoidance of complications. For example, undiagnosed or improperly treated strep can result in a rash known as scarlet fever, and more seriously, rheumatic fever. Proper, early treatment can prevent such complications. Diagnosis of viruses which will not require antibiotics can also help to provide the best supportive care and monitoring to avoid complications. Mononucleosis (Epstein-Barr virus) as an example may cause difficulty breathing if the tonsils become enlarged. Accurate diagnosis can provide for the best in attentive support and antimicrobial treatment. Utilizing the best in technology, Respi Peds Dx™ reduces false negative test results that can lead to a delayed diagnosis and poor clinical outcomes. Respi Peds Dx™ quickly identifies all organisms and pathogens in the pediatric respiratory tract and with our powerful Antibiotic Resistance Dx™ panel, VolenteDx detects potential bacterial antibiotic resistance, so effective supportive care and antibiotic treatment can begin as early as possible. Additionally, the combination of Respi Peds Dx™ and Antibiotic Resistance Dx™ can help physicians and facilities to strengthen antibiotic stewardship programs. VolenteDx brings together valuable tools for the best in pediatric respiratory diagnostics, avoidance of adverse events and prevention of unnecessary antibiotic prescribing.